[抗体与药物结合物的基础和创新]
1Hoshi University, Laboratory of Synthetic Biomolecular Chemistry.
Gan to kagaku ryoho. Cancer & chemotherapy
|August 27, 2024
概括
抗体-药物合物 (ADCs) 提高了针对性治疗的杆作用,以提高癌症治疗效果. 先进的策略和癌症免疫学见解对于最大限度地提高它们的持续治疗效果至关重要.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗体-药物合物 (ADC) 是已确立的癌症治疗药物.
- 目前正在进行的研究旨在进一步推进ADC技术.
- 了解ADC结构,机制和瘤微环境相互作用是关键.
研究的目的:
- 提供ADC结构和作用机制的概述.
- 探索生成同质ADC和旁观者效应的方法.
- 讨论下一代ADC策略及其与免疫治疗的整合.
主要方法:
- 审查ADC组件 (抗体,有效载荷,链接器) 和它们的功能.
- 分析ADC机制,包括抗原结合,内化和药物释放.
- 探索创新的ADC方法,如放射性免疫疗法和光免疫疗法.
主要成果:
- 通过有针对性的输送和受控释放,ADC扩大了治疗窗口.
- 同质的ADC生成和旁观者效应提高了疗效.
- 下一代策略和免疫疗法整合显示出有希望的结果.
结论:
- ADC的有效性依赖于向的输送,受控释放和癌症免疫学.
- 了解潜在的机制对于持续的治疗效果至关重要.
- 需要进一步研究ADC与其他疗法的整合.
更多相关视频
11:58Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
Published on: March 8, 2018
7.6K
09:39Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics DCAF
Published on: September 17, 2019
6.8K
相关概念视频
Antibody Structure and Classes
859
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
859
Antibody Actions
1.1K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.1K
Antibody Structure
59.6K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
59.6K
Hybridoma Technology
14.2K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.2K
Phase II Conjugation Reactions: Overview
173
Conjugation, a key component of phase II biotransformation reactions, is a vital process in drug detoxification. It involves transferring endogenous substances like glucuronic acid, sulfate, and glycine to drugs or their metabolites formed in phase I reactions. These conjugation reactions, often catalyzed by specific enzymes, transform potentially harmful metabolites into inactive, water-soluble forms easily excreted in urine or bile. By enhancing polarity and eliminating pharmacological...
173
Affinity and Avidity
35.9K
Overview
35.9K
